Cargando…
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
INTRODUCTION: Estrogen receptor positive breast cancers often have high levels of Mdm2. We investigated if estrogen signaling in such breast cancers occurred through an Mdm2 mediated pathway with subsequent inactivation of p53. METHODS: We examined the effect of long-term 17β-estradiol (E2) treatmen...
Autores principales: | Brekman, Angelika, Singh, Kathryn E, Polotskaia, Alla, Kundu, Nandini, Bargonetti, Jill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109566/ https://www.ncbi.nlm.nih.gov/pubmed/21223569 http://dx.doi.org/10.1186/bcr2804 |
Ejemplares similares
-
Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012) -
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway
por: Kundu, Nandini, et al.
Publicado: (2017) -
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death
por: Rosso, Melissa, et al.
Publicado: (2015) -
Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator
por: Okoro, Danielle R., et al.
Publicado: (2013) -
Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure
por: Shi, Menglu, et al.
Publicado: (2014)